- Twist Bioscience has come across my desk several times over the past couple of years, but I have always found an excuse to push it to the side.
- Twist offers some impressive products and services that could generate billions of dollars a year in revenue. The market is convinced and is trading TWST at a premium valuation.
- I provide my views on Twist's technology and its current valuation.
- The stock has been under pressure over the past several months, but has started to establish an uptrend from the May low. I attempt to find an entry point.
For further details see:
Twist Bioscience: Finding An Acceptable Valuation